Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials.

Background Various mechanisms link higher total homocysteine to higher insulin resistance (IR) and risk of type 2 diabetes (T2D). Folate supplementation is recognized as a way to lower homocysteine. However, randomized controlled trials (RCTs) show inconsistent results on IR and T2D outcomes. Objective The aim of this study was to examine the effect of folate supplementation on IR and T2D outcomes. Design We conducted a systematic literature search in PubMed, Web of Science, and EMBASE and prior systematic reviews and meta-analyses and identified 29 RCTs (22,250 participants) that assessed the effect of placebo-controlled folate supplementation alone or in combination with other B vitamins on fasting glucose, insulin, homeostasis model assessment for insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), or risk of T2D. The meta-analysis was conducted using both random- and fixed-effects models to calculate weighted mean differences (WMDs) or risk ratios with 95% CIs. Subgroup analyses were conducted based on intervention type (folate alone or in combination with other B vitamins), as well as analysis based on population characteristics, duration, dose, and change in homocysteine. Results When compared with placebo, folate supplementation lowered fasting insulin (WMD: -13.47 pmol/L; 95% CI: -21.41, -5.53 pmol/L; P < 0.001) and HOMA-IR (WMD: -0.57 units; 95% CI: -0.76, -0.37 units; P < 0.0001), but no overall effects were observed for fasting glucose or HbA1c. Heterogeneity was low in all meta-analyses, and subgroup analysis showed no signs of effect modification except for change in homocysteine, with the most pronounced effects in trials with a change of >2.5 µmol/L. Changes in homocysteine after folate supplementation correlated with changes in fasting glucose (β = 0.07; 95% CI: 0.01, 0.14; P = 0.025) and HbA1c (β = 0.46; 95% CI: 0.06, 0.85; P = 0.02). Only 2 studies examined folate supplementation on risk of T2D, and they found no change in RR (pooled RR: 0.91; 95% CI: 0.80, 1.04; P = 0.16). Conclusion Folate supplementation might be beneficial for glucose homeostasis and lowering IR, but at present there are insufficient data to conclusively determine the effect on development of T2D. This trial was registered on the Prospero database as CRD42016048254.

[1]  C. Schooling,et al.  The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. , 2018, Annals of epidemiology.

[2]  F. Kolahdooz,et al.  The Effects of Folate Supplementation on Diabetes Biomarkers Among Patients with Metabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Hormone and Metabolic Research.

[3]  Sang-Woon Choi,et al.  One-carbon metabolism and epigenetics. , 2017, Molecular aspects of medicine.

[4]  Jianping Li,et al.  Longitudinal association between fasting blood glucose concentrations and first stroke in hypertensive adults in China: effect of folic acid intervention. , 2017, The American journal of clinical nutrition.

[5]  Tom R. Gaunt,et al.  Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity , 2016, Nature.

[6]  F. Hou,et al.  Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial. , 2016, JAMA internal medicine.

[7]  F. Hu,et al.  Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta‐Analysis of Randomized Controlled Trials , 2016, Journal of the American Heart Association.

[8]  Y. Hamidian,et al.  The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome , 2016, Annals of Nutrition and Metabolism.

[9]  Ahmad Esmaillzadeh,et al.  Effects of long-term folate supplementation on metabolic status and regression of cervical intraepithelial neoplasia: A randomized, double-blind, placebo-controlled trial. , 2016, Nutrition.

[10]  Jianping Li,et al.  Effect of folic acid supplementation on risk of new‐onset diabetes in adults with hypertension in China: Findings from the China Stroke Primary Prevention Trial (CSPPT) , 2015, Journal of diabetes.

[11]  Hong Wang,et al.  Hyperhomocysteinemia and Hyperglycemia Induce and Potentiate Endothelial Dysfunction via μ-Calpain Activation , 2014, Diabetes.

[12]  Ahmad Esmaillzadeh,et al.  Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. , 2014, Molecular nutrition & food research.

[13]  Jinyan Huang,et al.  Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach , 2013, BMC Genomics.

[14]  R. S. Moraes,et al.  Short-term folinic acid supplementation improves vascular reactivity in HIV-infected individuals: a randomized trial. , 2013, Nutrition.

[15]  J. Rosenstock,et al.  Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. , 2013, The American journal of medicine.

[16]  Surasak Saokaew,et al.  Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. , 2012, Diabetes research and clinical practice.

[17]  M. Stampfer,et al.  Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. , 2011, JAMA.

[18]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[19]  B. P. Gargari,et al.  Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. , 2011, Diabetes research and clinical practice.

[20]  B. P. Gargari,et al.  Effect of Folic Acid Supplementation on Homocysteine, Serum Total Antioxidant Capacity, and Malondialdehyde in Patients with Type 2 Diabetes Mellitus , 2011, Journal of the American College of Nutrition.

[21]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[22]  H. Oflaz,et al.  Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency. , 2010, Archives of medical research.

[23]  D. Churchill,et al.  Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. , 2010, JAMA.

[24]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[25]  A. Cagnacci,et al.  High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study , 2009, European Journal of Clinical Nutrition.

[26]  JoAnn E. Manson,et al.  Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women , 2009, Diabetes.

[27]  Shan-chun Zhang,et al.  Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial. , 2008, Nutrition.

[28]  G. Hankey,et al.  The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis , 2008, BMC cardiovascular disorders.

[29]  Dou Jing-tao,et al.  Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes , 2008, Advances in therapy.

[30]  M. Boaz,et al.  Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients. , 2008, Atherosclerosis.

[31]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[32]  C. Vrints,et al.  Effect of folic acid on endothelial function following acute myocardial infarction. , 2007, The American journal of cardiology.

[33]  P. Flatt,et al.  Homocysteine-Induced Impairment of Insulin Secretion From Clonal Pancreatic BRIN-BD11 &bgr;-Cells Is Not Prevented by Catalase , 2007, Pancreas.

[34]  I. Mcdowell,et al.  High‐ but not low‐dose folic acid improves endothelial function in coronary artery disease , 2006, European journal of clinical investigation.

[35]  L. Brennan,et al.  Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion. , 2006, The Journal of endocrinology.

[36]  E. Ur,et al.  Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering , 2006, Vascular medicine.

[37]  T. Maruyama,et al.  Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects , 2006, European Journal of Clinical Nutrition.

[38]  E. Ferrannini,et al.  Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects , 2006, International Journal of Obesity.

[39]  B. Metzger,et al.  Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. , 2005, Diabetes care.

[40]  M. Landray,et al.  Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. , 2005, The American journal of clinical nutrition.

[41]  S. Panunzi,et al.  L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. , 2005, The Journal of clinical endocrinology and metabolism.

[42]  S. Fowler,et al.  Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. , 2005, Diabetes.

[43]  W. Sheu,et al.  Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women. , 2005, Life sciences.

[44]  A. Mangoni,et al.  Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. , 2005, American journal of hypertension.

[45]  V. Sánchez-Margalet,et al.  Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. , 2005, Journal of molecular endocrinology.

[46]  C. Stehouwer,et al.  No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. , 2004, The Netherlands journal of medicine.

[47]  L. Monti,et al.  Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. , 2004, European journal of endocrinology.

[48]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[49]  Jonathan Goodfellow,et al.  Folic Acid Improves Endothelial Function in Coronary Artery Disease via Mechanisms Largely Independent of Homocysteine Lowering , 2002, Circulation.

[50]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[51]  V. Sánchez-Margalet,et al.  Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. , 2001, Journal of molecular endocrinology.

[52]  D. Singer,et al.  Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. , 2001, Diabetes care.

[53]  R. Newcombe,et al.  Folate Improves Endothelial Function in Coronary Artery Disease: An Effect Mediated by Reduction of Intracellular Superoxide? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[54]  M. Buysschaert,et al.  Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. , 2000, Diabetes care.

[55]  J. Kooner,et al.  Improved Vascular Endothelial Function After Oral B Vitamins: An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine , 2000, Circulation.

[56]  L. Bouter,et al.  Follow-Up of the Hoorn Study Hyperhomocysteinemia Increases Risk of Death , Especially in Type 2 Diabetes : 5-Year , 2000 .

[57]  Carlsen,et al.  Folate administration reduces circulating homocysteine levels in NIDDM patients on long‐term metformin treatment , 1998, Journal of internal medicine.

[58]  T. Saldeen,et al.  Effects of fish oil supplemented with pyridoxine and folic acid on homocysteine, atherogenic index, fibrinogen and plasminogen activator inhibitor-1 in man , 1993 .

[59]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[60]  L. Bouter,et al.  Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[61]  D. Berry.  Subgroup analyses. , 1990, Biometrics.